Kidtrayze (Zinc Chloride, Potassium Iodide, Sodium Selenite, Copper Chloride Dihydrate, Manganese Chloride Tetr)

The active ingredients—zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate and manganese chloride tetr—are delivered directly into the bloodstream. Each trace element serves as a cofactor for specific enzymes, participates in hormone synthesis, and contributes to cellular respiration, thereby facilitating normal physiological processes during parenteral feeding.

The dose of Kidtrayze is individualized by the prescribing clinician based on the patient’s weight, laboratory values and overall nutritional plan. Healthcare professionals calculate the appropriate volume and concentration to meet the specific trace element requirements of each patient.

Safety data for Kidtrayze in pregnancy and lactation are limited. The decision to use it should be made by a qualified healthcare provider after weighing potential benefits against any unknown risks to the mother and fetus or infant.

To order Kidtrayze, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and necessary import documentation.

Kidtrayze combines five essential trace elements in a single sterile IV formulation, reducing the need for multiple separate infusions. Compared with products that contain only one or two minerals, Kidtrayze offers a broader spectrum of micronutrients, which can simplify dosing regimens and improve compliance in complex nutritional support protocols.

Kidtrayze must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken vigorously. Before administration, inspect the solution for particulate matter or discoloration and use aseptic technique to maintain sterility.

Kidtrayze is administered intravenously, typically as an additive to a total parenteral nutrition bag or as a separate infusion. The exact rate and volume are determined by the prescribing clinician and should be infused under controlled conditions with appropriate monitoring of the infusion site and patient vitals.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, significant electrolyte disturbances that can lead to cardiac arrhythmias, and organ toxicity (hepatic or renal) from excessive accumulation of trace elements. Prompt recognition and management of these events are essential.

Kidtrayze should be avoided in patients with known hypersensitivity to any of its components, those with uncontrolled electrolyte imbalances, or individuals receiving overlapping parenteral trace element preparations that could cause cumulative toxicity. Clinical judgment is required for patients with severe hepatic or renal impairment.